知镜 Cognispect · 医学文献与研究工作台

CCTA-Based Assessment of Coronary Calcium Burden, Inflammatory and Metabolic Biomarkers, and 3-Year Outcomes in Patients with Type 2 Diabetes Mellitus and Stable Ischemic Heart Disease.

Liu GA, Wu W, Li W, Zhou L, Cui J, Zhang R, Liu F.
Journal of inflammation research · 2026-08-06 · PMID 42591707

文献摘要

Background Coronary artery calcification (CAC) is common in patients with type 2 diabetes mellitus (T2DM) and stable ischemic heart disease (IHD). However, the associations of coronary calcium burden with inflammatory and metabolic biomarker profiles and subsequent clinical outcomes within this population remain incompletely characterized. Objective To examine the associations of coronary CT angiography (CCTA)-based coronary calcium burden with inflammatory and metabolic biomarkers and 3-year clinical outcomes in patients with T2DM and stable IHD. Methods In this retrospective observational study using routinely collected electronic medical record and CCTA data from a single tertiary hospital in Suzhou, China, we analyzed 3991 patients with T2DM and stable IHD who underwent CCTA between January 2016 and December 2022. Patients were stratified by coronary artery calcium score (CACS) as mild (>0-100), moderate (101-400), and severe (>400). Circulating interleukins (IL-1β, IL-6, IL-10, IL-35), TNF-α, TGF-β, and trimethylamine N-oxide (TMAO) were measured at baseline. The primary endpoint was 3-year major adverse cardiovascular and cerebrovascular events (MACCE). Results Higher CACS correlated with increased IL-1β and TMAO and decreased IL-10 and IL-35. Over three years, MACCE occurred in 2.9%, 20.1%, and 18.9% of the mild, moderate, and severe groups (P Conclusion CACS provided substantial incremental prognostic information beyond clinical variables, whereas IL-1β and IL-35 provided a further modest but statistically significant improvement in model discrimination. IL-35 should be regarded as an emerging, hypothesis-generating candidate biomarker rather than an established anti-calcific mediator. These observational findings do not establish causal mechanisms, and the prognostic utility of the combined imaging-biomarker model requires external validation before clinical implementation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。